ANNEX I, Decision_act (EU) 2018/945

In force

Anthrax

Botulism

Brucellosis

Campylobacter enteritis

Chikungunya virus disease

Chlamydial infection, including Chlamydial lymphogranuloma (venereum) (LGV)

Cholera

Creutzfeldt-Jakob disease

Cryptosporidiosis

Dengue

Diphtheria

Echinococcosis

Giardiasis (lambliasis)

Gonococcal infection

Haemophilus influenzae infection, invasive disease

Acute hepatitis A

Hepatitis B

Hepatitis C

Human immunodeficiency virus (HIV) infection and Acquired immunodeficiency syndrome (AIDS)

Influenza

Influenza A/H5N1

Legionnaires' disease

Leptospirosis

Listeriosis

Lyme neuroborreliosis

Malaria

Measles

Meningococcal infection, invasive disease

Mumps

Pertussis

Plague

Streptococcus pneumoniae infection, invasive disease

Acute poliomyelitis

Q fever

Rabies

Rubella

Congenital rubella syndrome

Salmonella enteritis

Severe acute respiratory syndrome (SARS)

Shiga toxin/verocytotoxin-producing E. coli infection (STEC/VTEC), including Haemolytic-uraemic syndrome (HUS)

Shigellosis

Smallpox

Syphilis

Congenital syphilis

Tetanus

Tick-borne viral encephalitis

Congenital toxoplasmosis

Trichinellosis

Tuberculosis

Tularaemia

Typhoid and paratyphoid fevers

Viral haemorrhagic fevers (VHF)

West Nile virus infection

Yellow fever

Enteritis due to Yersinia enterocolitica or Yersinia pseudotuberculosis

Zika virus disease

Congenital Zika virus disease

2.1. Nosocomial infections

2.2. Antimicrobial resistance